The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.

The NIH projected the cut will save it $4 billion during the current federal fiscal year, which ends September 30. That’s nearly half of the $9 billion that the NIH said it set aside for overhead ...

In statements and interviews with The Crimson, nine life sciences researchers at Harvard said limits on indirect cost ...

ASX is in a strong financial position due to its high margins, capital-light business model, and limited debt as of December 2024. ASX also maintains an effective monopoly for most of its businesses, ...

X Genomics Inc . (NASDAQ:TXG) reported its Q4 2024 earnings, revealing a larger-than-expected loss per share and a decline in revenue compared to the previous year. The company posted an EPS of -$0.40 ...